Metabolic and cardiorespiratory effects of decreasing lung hyperinflation with budesonide/formoterol in COPD: a randomized, double-crossover, placebo-controlled, multicenter trial.
- DOI
- 10.1186/s12931-020-1288-3
- Published
- 2020 Jan 20
- Container
- Respiratory research
- Publisher
- figshare
- Open access
- yes
Credibility signals
uncertain Score 61/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- supportingPublication license: A publication license was supplied: https://creativecommons.org/licenses/by/4.0. Presence improves reuse transparency, not research validity.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12931-020-1288-3,
title = {Metabolic and cardiorespiratory effects of decreasing lung hyperinflation with budesonide/formoterol in COPD: a randomized, double-crossover, placebo-controlled, multicenter trial.},
author = {Divo MJ and DePietro MR and Horton JR and Maguire CA and Celli BR},
year = {2020},
journal = {Respiratory research},
doi = {10.1186/s12931-020-1288-3},
url = {https://doi.org/10.1186/s12931-020-1288-3}
}RIS
TY - JOUR TI - Metabolic and cardiorespiratory effects of decreasing lung hyperinflation with budesonide/formoterol in COPD: a randomized, double-crossover, placebo-controlled, multicenter trial. AU - Divo MJ AU - DePietro MR AU - Horton JR AU - Maguire CA AU - Celli BR PY - 2020 JO - Respiratory research DO - 10.1186/s12931-020-1288-3 UR - https://doi.org/10.1186/s12931-020-1288-3 ER -
APA
MJ, D., MR, D., JR, H., CA, M., & BR, C. (2020). Metabolic and cardiorespiratory effects of decreasing lung hyperinflation with budesonide/formoterol in COPD: a randomized, double-crossover, placebo-controlled, multicenter trial.. Respiratory research. https://doi.org/10.1186/s12931-020-1288-3
Source records
- pubmed · retrieved 2026-11-10T18:12:36.294Z
- europe-pmc · retrieved 2026-11-10T18:12:36.295Z
- datacite · retrieved 2026-11-10T18:12:36.287Z
- datacite · retrieved 2026-11-10T18:12:36.287Z
- doaj · retrieved 2026-11-10T18:12:36.284Z